Doctors Insurance Physicians Side effects 
World of DTC Marketing
AUGUST 29, 2022
That information should be shared with HCPs and insurers to understand better the barriers and opportunities of treating patients. The research showed that patients wanted to understand how the drug works and the potential side effects. HCPs want to understand their patients better as insurers require better patient outcomes.
World of DTC Marketing
JULY 17, 2022
But before the company can make Wegovy mainstream, it has to convince doctors to prescribe it and insurers and governments to pay for it. It has to persuade patients to sign up for some heinous side effects. Wegovy’s monthly list price in the US is about $1,350, and some insurers are not yet covering the drug.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
World of DTC Marketing
JANUARY 1, 2022
More and more patients demand a level of service they want with the increased costs of health insurance premiums. 1ne: The value proposition of prescription drugs still outweighs potential side effects – Wegovy’s demand quickly exceeded supply after the FDA approved once-weekly semaglutide injections.
World of DTC Marketing
JUNE 27, 2021
Yet the media has led with “diabetes drug leads to major weight loss” Will doctors inform patients? Wegovy’s most common side effects were gastrointestinal problems, including nausea, diarrhea, and vomiting, which 80% of patients reported, according to USA Today.
World of DTC Marketing
JULY 5, 2022
Lilly’s new diabetes drug is being talked about all over social media because of its weight loss properties, but what’s not mentioned is that it requires a diet modification and has side effects that can cause more severe health issues. Why don’t doctors have the “the talk”?
World of DTC Marketing
JUNE 15, 2021
QUICK POINTS: Telemedicine claims as a proportion of all commercial health insurance claims decreased by 5.1% Doctors using telemedicine software are not sure of its value to patients and believe telehealth may pose risks. nationwide from February to March, after a steeper decline of 15.7% Cases declined as a result.
PM360
OCTOBER 13, 2023
Doctor Docs: Targeting Trust Between Pharma and HCPs A new study shows the crucial link in pharma marketers’ digital engagement strategy with HCPs is in jeopardy—trust. doctors are calling two particular drugs “paradigm-shifting”—tirzepatide, sold as Mounjaro , and semaglutide, sold as the brands Ozempic , Wegovy , and Rybelsus.
Expert insights. Personalized for you.
203 
Let's personalize your content